These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 19245700

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Current management of anemia in adult hemodialysis patients with end-stage renal disease.
    Frankenfield DL, Johnson CA.
    Am J Health Syst Pharm; 2002 Mar 01; 59(5):429-35. PubMed ID: 11887409
    [Abstract] [Full Text] [Related]

  • 3. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project.
    Frankenfield D, Johnson CA, Wish JB, Rocco MV, Madore F, Owen WF.
    Kidney Int; 2000 Feb 01; 57(2):578-89. PubMed ID: 10652035
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK, Morgenstern T.
    Dtsch Med Wochenschr; 2004 Sep 03; 129(36):1849-53. PubMed ID: 15368155
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A study of the response of elderly patients with end-stage renal disease to epoetin alfa or beta.
    Nicholas JC.
    Drugs Aging; 2004 Sep 03; 21(3):187-201. PubMed ID: 14979736
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
    McCarthy JT, Regnier CE, Loebertmann CL, Bergstralh EJ.
    Am J Nephrol; 2000 Sep 03; 20(6):455-62. PubMed ID: 11146312
    [Abstract] [Full Text] [Related]

  • 13. Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin.
    Kapoian T, O'Mara NB, Singh AK, Moran J, Rizkala AR, Geronemus R, Kopelman RC, Dahl NV, Coyne DW.
    J Am Soc Nephrol; 2008 Feb 03; 19(2):372-9. PubMed ID: 18216316
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Iron supplementation in haemodialysis--practical clinical guidelines.
    Silva J, Andrade S, Ventura H, Santos JP, Colaço S, Oliveira C, Ponce P.
    Nephrol Dial Transplant; 1998 Oct 03; 13(10):2572-7. PubMed ID: 9794562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.